Literature DB >> 33353064

Histone Variant H3.3 Mutations in Defining the Chromatin Function in Mammals.

Matteo Trovato1,2, Vibha Patil1, Maja Gehre1,2, Kyung Min Noh1.   

Abstract

The systematic mutation of histone 3 (H3) genes in model organisms has proven to be a valuable tool to distinguish the functional role of histone residues. No system exists in mammalian cells to directly manipulate canonical histone H3 due to a large number of clustered and multi-loci histone genes. Over the years, oncogenic histone mutations in a subset of H3 have been identified in humans, and have advanced our understanding of the function of histone residues in health and disease. The oncogenic mutations are often found in one allele of the histone variant H3.3 genes, but they prompt severe changes in the epigenetic landscape of cells, and contribute to cancer development. Therefore, mutation approaches using H3.3 genes could be relevant to the determination of the functional role of histone residues in mammalian development without the replacement of canonical H3 genes. In this review, we describe the key findings from the H3 mutation studies in model organisms wherein the genetic replacement of canonical H3 is possible. We then turn our attention to H3.3 mutations in human cancers, and discuss H3.3 substitutions in the N-terminus, which were generated in order to explore the specific residue or associated post-translational modification.

Entities:  

Keywords:  H3; H3.3; PTMs; chromatin; epigenetics; histone variants; histones; post-translational modifications

Mesh:

Substances:

Year:  2020        PMID: 33353064      PMCID: PMC7766983          DOI: 10.3390/cells9122716

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  155 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

2.  Histone modification: cause or cog?

Authors:  Steven Henikoff; Ali Shilatifard
Journal:  Trends Genet       Date:  2011-07-20       Impact factor: 11.639

3.  Serine 31 phosphorylation of histone variant H3.3 is specific to regions bordering centromeres in metaphase chromosomes.

Authors:  Sandra B Hake; Benjamin A Garcia; Monika Kauer; Stephen P Baker; Jeffrey Shabanowitz; Donald F Hunt; C David Allis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

4.  Expression patterns and post-translational modifications associated with mammalian histone H3 variants.

Authors:  Sandra B Hake; Benjamin A Garcia; Elizabeth M Duncan; Monika Kauer; Graham Dellaire; Jeffrey Shabanowitz; David P Bazett-Jones; C David Allis; Donald F Hunt
Journal:  J Biol Chem       Date:  2005-11-02       Impact factor: 5.157

Review 5.  Perceiving the epigenetic landscape through histone readers.

Authors:  Catherine A Musselman; Marie-Eve Lalonde; Jacques Côté; Tatiana G Kutateladze
Journal:  Nat Struct Mol Biol       Date:  2012-12       Impact factor: 15.369

6.  Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.

Authors:  Kristel M Dorighi; Tomek Swigut; Telmo Henriques; Natarajan V Bhanu; Benjamin S Scruggs; Nataliya Nady; Christopher D Still; Benjamin A Garcia; Karen Adelman; Joanna Wysocka
Journal:  Mol Cell       Date:  2017-05-05       Impact factor: 17.970

7.  Childhood cerebellar tumours mirror conserved fetal transcriptional programs.

Authors:  Maria C Vladoiu; Ibrahim El-Hamamy; Laura K Donovan; Nada Jabado; Lincoln Stein; Michael D Taylor; Hamza Farooq; Borja L Holgado; Yogi Sundaravadanam; Vijay Ramaswamy; Liam D Hendrikse; Sachin Kumar; Stephen C Mack; John J Y Lee; Vernon Fong; Kyle Juraschka; David Przelicki; Antony Michealraj; Patryk Skowron; Betty Luu; Hiromichi Suzuki; A Sorana Morrissy; Florence M G Cavalli; Livia Garzia; Craig Daniels; Xiaochong Wu; Maleeha A Qazi; Sheila K Singh; Jennifer A Chan; Marco A Marra; David Malkin; Peter Dirks; Lawrence Heisler; Trevor Pugh; Karen Ng; Faiyaz Notta; Eric M Thompson; Claudia L Kleinman; Alexandra L Joyner
Journal:  Nature       Date:  2019-05-01       Impact factor: 49.962

8.  H3.3 actively marks enhancers and primes gene transcription via opening higher-ordered chromatin.

Authors:  Ping Chen; Jicheng Zhao; Yan Wang; Min Wang; Haizhen Long; Dan Liang; Li Huang; Zengqi Wen; Wei Li; Xia Li; Hongli Feng; Haiyong Zhao; Ping Zhu; Ming Li; Qian-fei Wang; Guohong Li
Journal:  Genes Dev       Date:  2013-09-24       Impact factor: 11.361

9.  UBN1/2 of HIRA complex is responsible for recognition and deposition of H3.3 at cis-regulatory elements of genes in mouse ES cells.

Authors:  Chaoyang Xiong; Zengqi Wen; Juan Yu; Jun Chen; Chao-Pei Liu; Xiaodong Zhang; Ping Chen; Rui-Ming Xu; Guohong Li
Journal:  BMC Biol       Date:  2018-10-03       Impact factor: 7.431

10.  EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency.

Authors:  Xiaohua Shen; Yingchun Liu; Yu-Jung Hsu; Yuko Fujiwara; Jonghwan Kim; Xiaohong Mao; Guo-Cheng Yuan; Stuart H Orkin
Journal:  Mol Cell       Date:  2008-11-21       Impact factor: 17.970

View more
  3 in total

1.  Acetylation-Specific Interference by Anti-Histone H3K9ac Intrabody Results in Precise Modulation of Gene Expression.

Authors:  Simonetta Lisi; Matteo Trovato; Ottavia Vitaloni; Marco Fantini; Michele Chirichella; Paola Tognini; Sara Cornuti; Mario Costa; Marco Groth; Antonino Cattaneo
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

Review 2.  Transcriptional Regulation of Endogenous Retroviruses and Their Misregulation in Human Diseases.

Authors:  Qian Zhang; Juan Pan; Yusheng Cong; Jian Mao
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

Review 3.  The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes.

Authors:  Tasnim H Beacon; Geneviève P Delcuve; Camila López; Gino Nardocci; Igor Kovalchuk; Andre J van Wijnen; James R Davie
Journal:  Clin Epigenetics       Date:  2021-07-08       Impact factor: 6.551

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.